Related Experiment Video
Updated: Jun 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association between anxiety and C-reactive protein levels in stable coronary heart disease patients
Bettina Bankier1, Justine Barajas, Abelardo Martinez-Rumayor
1Department of Psychiatry and Psychotherapy, Medical University Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria. bettina.bankier@meduniwien.ac.at
Insights
Anxiety is linked to elevated C-reactive protein (CRP) levels in stable coronary heart disease (CHD) patients. This suggests a potential biological connection between anxiety and cardiovascular risk, warranting further investigation.
Area of Science:
- Cardiology
- Psychiatry
- Biomarkers
Background:
- Anxiety is common in stable coronary heart disease (CHD) patients.
- The biological mechanisms linking anxiety and CHD are not fully understood.
Purpose of the Study:
- To evaluate anxiety in stable CHD patients.
- To examine the relationship between anxiety and cardiac biomarkers like C-reactive protein (CRP).
Main Methods:
- Included 43 CHD patients with anxiety disorder and 42 without.
- Used the Structured Clinical Interview for DSM-IV for diagnosis.
Main Results:
- Anxiety disorder was associated with higher CRP levels in CHD patients.
- This association remained significant after adjusting for demographic and clinical factors.
Conclusions:
- Anxiety shows a significant association with CHD risk.
- A potential biological link exists between anxiety and elevated CRP, a key prognostic biomarker.
- Anxiety disorders should be considered alongside depressive disorders in CHD research.
Background:
Anxiety is highly prevalent among patients with stable coronary heart disease (CHD). However, the biologic effects that may connect these two seemingly unrelated disorders is not well understood.
Objective:
This study aimed for a comprehensive evaluation of anxiety in stable CHD patients, in addition to cardiac biomarkers such as C-reactive protein (CRP), troponin T, and amino-terminal pro-B-type brain natriuretic peptide.
Method:
The study included 43 CHD patients with anxiety disorder and 42 CHD patients without psychiatric disorder given the Structured Clinical Interview for DSM-IV.
Results:
Regression analyses showed an association between anxiety (anxiety disorder, not otherwise specified) and CRP levels, despite model adjustment for various related demographic and clinical variables. Anxiety was associated with CRP levels.
Conclusion:
There are significant associations between anxiety and CHD risk, with a potential biologic link between anxiety and elevations in a biomarker with powerful prognostic risk, namely CRP. It is not clear whether this association is directly causal or relates to other medical processes among patients with heightened anxiety. The findings suggest that the current focus on depressive disorders with respect to biomarkers and CHD outcomes should be broadened to include anxiety disorders, as well.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT